Buprenorphine

3 trials 2 recruiting NNeurology/Psychiatry

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

3 Sponsors

2 Countries

Phase II

Phase IV

Phase II: 2 Phase IV: 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 1 Indivior Inc. 1 Linkopings Universitet 1

All trials

3 total

The dual orexin receptor antagonist daridorexant as an adjunct to improve buprenorphine maintenance therapy of opioid use disorder Recruiting

2024-517482-16-00 Phase II 1 country Linkopings Universitet
Add-on buprenorphine at analgesic doses for the treatment of severe suicidal ideas during a major depressive episode Recruiting

2024-512445-17-00 Phase II 1 country Centre Hospitalier Universitaire De Nimes
Long Term Outcomes Ended

2023-505098-34-00 Phase IV 1 country Indivior Inc.

Showing 1–3 of 3 trials

← All drugs A–Z